Gene · 8630
Papers1,491
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,491
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review. | Front Med (Lausanne) | 2023 | 37265486 | PubTator, text mining | PubMed |
| Gut microbiota-derived lipid metabolites facilitate regulatory T cell differentiation. | Sci Rep | 2023 | 37264064 | PubTator, text mining | PubMed |
| Comparative Transcriptomic Analysis of Three Common Liver Cell Lines. | Int J Mol Sci | 2023 | 37240140 | PubTator, text mining | PubMed |
| The Action of Chemical Denaturants: From Globular to Intrinsically Disordered Proteins. | Biology (Basel) | 2023 | 37237566 | PubTator, text mining | PubMed |
| Lipid droplet biogenesis and functions in health and disease. | Nat Rev Endocrinol | 2023 | 37221402 | PubTator, text mining | PubMed |
| New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches. | Chin Herb Med | 2023 | 37220535 | PubTator, text mining | PubMed |
| Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy. | Front Pharmacol | 2023 | 37214434 | PubTator, text mining | PubMed |
| Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents. | J Enzyme Inhib Med Chem | 2023 | 37184042 | PubTator, text mining | PubMed |
| NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. | Int J Mol Sci | 2023 | 37175412 | PubTator, text mining | PubMed |
| Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine. | Molecules | 2023 | 37175270 | PubTator, text mining | PubMed |
| Androgen signalling in the ovaries and endometrium. | Mol Hum Reprod | 2023 | 37171897 | PubTator, text mining | PubMed |
| SELENOP modifies sporadic colorectal carcinogenesis and WNT signaling activity through LRP5/6 interactions. | J Clin Invest | 2023 | 37166989 | PubTator, text mining | PubMed |
| Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer. | J Transl Med | 2023 | 37147632 | PubTator, text mining | PubMed |
| Advances in the genetics of nonalcoholic fatty liver disease. | Curr Opin Gastroenterol | 2023 | 37144531 | PubTator, text mining | PubMed |
| Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5H)-one Derivatives with Potential Anticancer, Antioxidant, and 11β-HSD Inhibitory Activities. | Int J Mol Sci | 2023 | 37108415 | PubTator, text mining | PubMed |
| Identification of Differentially Expressed Genes and Molecular Pathways Involved in Osteoclastogenesis Using RNA-seq. | Genes (Basel) | 2023 | 37107674 | PubTator, text mining | PubMed |
| Mode of Action of Heat Shock Protein (HSP) Inhibitors against Viruses through Host HSP and Virus Interactions. | Genes (Basel) | 2023 | 37107550 | PubTator, text mining | PubMed |
| Herbal/Natural Compounds Resist Hallmarks of Brain Aging: From Molecular Mechanisms to Therapeutic Strategies. | Antioxidants (Basel) | 2023 | 37107295 | PubTator, text mining | PubMed |
| Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1. | Front Cardiovasc Med | 2023 | 37077734 | PubTator, text mining | PubMed |
| Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic. | Mol Cancer Ther | 2023 | 37067909 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8630/papers?page=11